New formulated "DOX-MTX-loaded Nanoparticles" Down-regulate HER2 Gene Expression and Improve the Clinical Outcome in OSCCs Model in Rat: the Effect of IV and Oral Modalities

Prognostic factors in squamous cell carcinoma of the oral cavity

(2015) José Raphael de Moura Campos Montoro et al.   Brazilian Journal of Otorhinolaryngology

Expression of EGFR and p53 in Head and Neck Tumors among Sudanese Patients

(2014) Mustafa Saadalnour Abusail et al.   Asian Pacific Journal of Cancer Prevention

Role of Concomitant Chemoradiation in Locally Advanced Head and Neck Cancers

(2014) Savita Lasrado et al.   Asian Pacific Journal of Cancer Prevention

Novel DOX-MTX Nanoparticles Improve Oral SCC Clinical Outcome by Down Regulation of Lymph Dissemination Factor VEGF-C Expression in vivo: Oral and IV Modalities

(2014) Mehran Mesgari Abbasi et al.   Asian Pacific Journal of Cancer Prevention

Methotrexate in Rheumatoid Arthritis: Optimizing Therapy Among Different Formulations. Current and Emerging Paradigms

(2014) Paola Cipriani et al.   CLINICAL THERAPEUTICS

Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs

(2014) Roya Salehi et al.   JOURNAL OF DRUG TARGETING

Efficacy and Safety of Concomitant Chemoradiotherapy with Cisplatin and Docetaxel in Patients with Locally Advanced Squamous Cell Head and Neck Cancers

(2013) Meltem Baykara et al.   Asian Pacific Journal of Cancer Prevention

Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment

(2013) Hoang Hanh Phuoc Duong et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

HER2/neu Expression in Head and Neck Squamous Cell Carcinoma Patients is not Significantly Elevated

(2012) Yasaman Sardari et al.   Asian Pacific Journal of Cancer Prevention

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

(2012) Oktay Tacar et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability

(2011) Derajram M. Benival et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2

(2010) Wen-Yu Huang et al.   BIOCHEMICAL PHARMACOLOGY

Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis

(2010) Barbara Rossi et al.   BMC MUSCULOSKELETAL DISORDERS

Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats

(2008) D. R. Kalaria et al.   PHARMACEUTICAL RESEARCH